Marko Stankic has been involved in life sciences-related strategic consulting, finance, and scientific research since 2004. Prior to joining Blue Matter in 2016, Marko was a Senior Consultant at Deloitte, a Consultant at Novartis, and a Fund Manager at BR Venture Fund. His research background includes many years at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital. Marko earned a Ph.D. in Cancer Biology and Genetics at the Weill Cornell School of Medical Sciences, an MBA at the Cornell Johnson Graduate School of Management, and a BA in Molecular Biochemistry and Mathematics at Whittier College.